📋 OUTLOOK THERAPEUTICS, INC. (OTLK) - Financial Results
Filing Date: 2026-08-14
Accepted: 2026-08-14 08:00:49
Event Type: Financial Results
Event Details:
OUTLOOK THERAPEUTICS, INC. (OTLK) Reports the reporting period Financial Results
OUTLOOK THERAPEUTICS, INC. (OTLK) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 17
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 11242
targeting strategy to prioritize retina practices with the greatest potential for early adoption and is building its commercial team with experienced leaders with deep expertise in retina, product launches, and the increasingly competitive and complex wet AMD and anti-VEGF market. The Company’s launch and go-to-market strategy is designed to reflect the evolving biosimilar landscape, affordability considerations, and the potential for additional market entrants, while supporting broad patient access and reimbursement. As part of these efforts, the Company plans to submit an application for a permanent Healthcare Common Procedure Coding System or HCPCS code by October 1, 2026
📋 OUTLOOK THERAPEUTICS, INC. (OTLK) - Financial Results
Filing Date: 2026-08-14
Accepted: 2026-08-14 08:00:49
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: